Oxygen Biotherapeutics (NASDAQ:OXBT) is scaling back global sales and marketing plans for its only commercialized product to focus on just two U.S. states following the termination of agreements with distributors in Switzerland and Mexico. Instead of selling its skin-care product Dermacyte in select global markets, Oxygen said it will now focus on selling in North […]
Ischemic stroke is the target of a new partnership between Oxygen Biotherapeutics (NASDAQ:OXBT) and Aurum Biosciences that aims to develop a diagnostic and a treatment for the condition. The agreement will pair the companies’ respective technologies: Aurum’s magnetic resonance imaging (MRI) technology has the potential to map salvageable tissue in the brain after a stroke […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Oxygen Biotherapeutics (NASDAQ:OXBT) plans to raise up to $7.5 million through a private placement with two unnamed institutional investors, financing that will be directed to the company’s drug pipeline that includes a clinical stage compound for treating traumatic brain injury. Morrisville, North Carolina-based Oxygen focuses on therapies that enhance the delivery of oxygen to damaged […]
The shakeout at Oxygen Biotherapeutics (NASDAQ:OXBT) continues with two board members of the biotechnology company resigning in the wake of disclosures of alleged improprieties leading to the ouster of former CEO Chris Stern. Morrisville, North Carolina-based Oxygen said the resignations of Rene Eckert and J. Melville Engle were not the result of any disagreement with […]
An audit investigation into former Oxygen Biotherapeutics (NASDAQ:OXBT) CEO Chris Stern concluded that Stern lied about his academic background and engaged in undisclosed securities deals with a vendor that he later tried to cover up. The audit report outlining the findings was included in the company’s quarterly report. Stern’s position as chairman and CEO of […]
Oxygen Biotherapeutics (NASDAQ:OXBT) is searching for a new top executive after terminating CEO Chris Stern in connection with an audit investigation. Morrisville, North Carolina-based Oxygen Biotherapeutics disclosed Stern’s termination in a securities filing Wednesday after the markets closed. The filing stated that Stern was terminated “for cause” in connection with an audit committee investigation “concerning […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
North Carolina biopharmaceutical company Oxygen Biotherapeutics (NASDAQ:OXBT) is teaming with a Scotland company to see if their respective technologies can work together in improving how to see and intervene in a stroke. Morrisville, North Carolina-based Oxygen Biotherapeutics announced on Monday a letter of intent to conduct preclinical research with Aurum Biosciences, which is based in […]
Oxygen Biotherapeutics (NASDAQ:OXBT) plans to expand its traumatic brain injury clinical trial to India and the drug development company is now looking for a pharmaceutical partner who could help take its experimental treatment through clinical trials. Morrisville, North Carolina-based Oxygen Biotherapeutics has been studying a treatment that enhances the delivery of oxygen to injured tissue, […]
Oxygen Biotherapeutics President and COO Richard Kiral is retiring today after more than a decade at the pharmaceutical development company. Kiral’s employment agreement with Oxygen Biotherapeutics (NASDAQ:OXBT) allows him to retire after reaching age 70, which occurred earlier this year. On March 28, the Morrisville, North Carolina-based company entered into a resignation of employment and […]